首页> 外文期刊>Nephron >The kidney evaluation and awareness program in sheffield (KEAPS): A community-based screening for microalbuminuria in a british population
【24h】

The kidney evaluation and awareness program in sheffield (KEAPS): A community-based screening for microalbuminuria in a british population

机译:谢菲尔德肾脏评估和认识计划(KEAPS):基于社区的英国人群微量白蛋白尿筛查

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Objectives: Microalbuminuria (MA) detects subjects at risk for cardiovascular disease (CVD) and chronic kidney disease (CKD) among diabetics, hypertensives and the general population. There is still a paucity of data on prevalence and risk factors for MA in the UK. We examined in a cross-sectional study, the prevalence and risk factors for MA in the general population of Sheffield, UK. Methods: The study was conducted among participants of the Kidney Evaluation and Awareness Program in Sheffield (KEAPS), a population-based screening program for MA. The screening tools included a questionnaire collating information on demographics, lifestyle, medical and family history of diabetes mellitus, hypertension and CKD. MA measurements were obtained by immunonephelometry, and MA thresholds were defined using the albumin-creatinine ratio. Results: The prevalence of MA was 7.1% in a random sample of a Sheffield-based population screened only once. The prevalence was 6.2% in the non-diabetic and non-hypertensive subjects. The prevalence of MA was only 1.3% in the subjects without any known risk factor, such as old age, diabetes, hypertension, obesity or CVD. The prevalence of MA could be overestimated as it was based on a single albumin-creatinine ratio testing. The independent predictor variables associated with the presence of MA in a mutually adjusted logistic regression model were: age (OR = 1.012, 95% CI: 1.00-1.02), diabetes (OR = 3.25, 95% CI: 1.30-8.13), obesity (OR = 4.09, 95% CI: 1.71-9.80) and family history of hypertension (OR = 1.87, 95% CI: 1.00-3.47). Conclusions: The main determinants of MA were increased age, diabetes, obesity and family history of hypertension. On the population level, obesity as a risk factor for MA is less well documented; in this study obesity had greater odds for MA than diabetes and hypertension.
机译:背景/目的:微量白蛋白尿(MA)可在糖尿病患者,高血压患者和普通人群中检测出患有心血管疾病(CVD)和慢性肾脏病(CKD)风险的对象。在英国,关于MA的患病率和危险因素的数据仍然很少。我们在一项横断面研究中检查了英国谢菲尔德总人口中MA的患病率和危险因素。方法:本研究在谢菲尔德肾脏评估和意识计划(KEAPS)的参与者中进行,该计划是基于人群的MA筛查计划。筛查工具包括一份问卷,以整理有关人口统计学,生活方式,糖尿病的医学史和家族史,高血压和CKD的信息。通过免疫比浊法获得MA测量值,并使用白蛋白-肌酐比值定义MA阈值。结果:在仅筛选一次的基于谢菲尔德的人群的随机样本中,MA的患病率为7.1%。在非糖尿病和非高血压受试者中,患病率为6.2%。没有年龄,糖尿病,高血压,肥胖或CVD等已知危险因素的受试者中,MA的患病率仅为1.3%。 MA的患病率可能是高估,因为它是基于单个白蛋白-肌酐比值测试的。在相互调整的逻辑回归模型中,与MA存在相关的独立预测变量为:年龄(OR = 1.012,95%CI:1.00-1.02),糖尿病(OR = 3.25,95%CI:1.30-8.13),肥胖(OR = 4.09,95%CI:1.71-9.80)和高血压家族史(OR = 1.87,95%CI:1.00-3.47)。结论:MA的主要决定因素是年龄增加,糖尿病,肥胖和高血压家族史。从人群的角度来看,肥胖是MA的危险因素,文献记载不多。在这项研究中,肥胖的MA几率比糖尿病和高血压高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号